Miguel Viñas Ciordia-rekin lankidetzan egindako argitalpenak (9)

2020

  1. iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 858-870

2017

  1. Benznidazole nanoformulates: A chance to improve therapeutics for Chagas disease

    American Journal of Tropical Medicine and Hygiene, Vol. 97, Núm. 5, pp. 1469-1476

  2. Determination of the spatiotemporal dependence of Pseudomonas aeruginosa biofilm viability after treatment with NLC-colistin

    International Journal of Nanomedicine, Vol. 12, pp. 4409-4413

  3. Free and nanoencapsulated tobramycin: Effects on planktonic and biofilm forms of pseudomonas

    Microorganisms, Vol. 5, Núm. 3

2016

  1. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients

    Journal of Cystic Fibrosis, Vol. 15, Núm. 5, pp. 611-618

  2. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 498, Núm. 1-2, pp. 263-273

  3. Stability study of sodium colistimethate-loaded lipid nanoparticles

    Journal of Microencapsulation, Vol. 33, Núm. 7, pp. 636-645

2015

  1. Antibióticos nanoencapsulados en el combate contra las infecciones respiratorias por "Pseudomonas aeruginosa"

    Avances en microbiología

2014

  1. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 477, Núm. 1-2, pp. 485-494